Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Rim Lee

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Genes|August 26, 2022
Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular CarcinomaSe Young Jang, Gyeonghwa Kim, Won Young Tak, et al.
Biomarkers in Medicine|September 8, 2018
Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinomaJun Sik Yoon, Gyeonghwa Kim, Yu Rim Lee, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty LiverMin-Kyu Kang, Jung-Hun Baek, Young-Oh Kweon, et al.
Scientific Reports|July 23, 2021
Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinomaGyeonghwa Kim, Ja Ryung Han, Soo Young Park, et al.
Journal of Korean Medical Science|April 27, 2021
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic PatientsDavid Sooik Kim, Soo Young Park, Beom Kyung Kim, et al.
Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
Gastroenterology|January 31, 2026
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease SubtypesGi-Ae Kim, Heejoon Jang, Moon Young Kim, et al.
Life (Basel, Switzerland)|October 7, 2020
Plasma Long Noncoding RNA <i>LeXis</i> is a Potential Diagnostic Marker for Non-Alcoholic SteatohepatitisJung Gil Park, Gyeonghwa Kim, Se Young Jang, et al.
Clinical and Molecular Hepatology|October 15, 2020
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South KoreaYu Rim Lee, Min Kyu Kang, Jeong Eun Song, et al.
Gut and Liver|March 30, 2021
Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic ImpairmentJeong Eun Song, Min Kyu Kang, Yu Rim Lee, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Genes|August 26, 2022
Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular CarcinomaSe Young Jang, Gyeonghwa Kim, Won Young Tak, et al.
Biomarkers in Medicine|September 8, 2018
Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinomaJun Sik Yoon, Gyeonghwa Kim, Yu Rim Lee, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty LiverMin-Kyu Kang, Jung-Hun Baek, Young-Oh Kweon, et al.
Scientific Reports|July 23, 2021
Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinomaGyeonghwa Kim, Ja Ryung Han, Soo Young Park, et al.
Journal of Korean Medical Science|April 27, 2021
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic PatientsDavid Sooik Kim, Soo Young Park, Beom Kyung Kim, et al.
Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.
Gastroenterology|January 31, 2026
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease SubtypesGi-Ae Kim, Heejoon Jang, Moon Young Kim, et al.
Life (Basel, Switzerland)|October 7, 2020
Plasma Long Noncoding RNA <i>LeXis</i> is a Potential Diagnostic Marker for Non-Alcoholic SteatohepatitisJung Gil Park, Gyeonghwa Kim, Se Young Jang, et al.
Clinical and Molecular Hepatology|October 15, 2020
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South KoreaYu Rim Lee, Min Kyu Kang, Jeong Eun Song, et al.
Gut and Liver|March 30, 2021
Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic ImpairmentJeong Eun Song, Min Kyu Kang, Yu Rim Lee, et al.
Pageof 12